A substance being studied in the treatment of cancer. RPI.4610 is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called Angiozyme.
Leave a Comment
You must be logged in to post a comment.